Literature DB >> 21251656

Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice.

Chie Hayashi1, Jason Viereck, Ning Hua, Alkystis Phinikaridou, Andrés G Madrigal, Frank C Gibson, James A Hamilton, Caroline A Genco.   

Abstract

OBJECTIVE: Studies in humans support a role for the oral pathogen Porphyromonas gingivalis in the development of inflammatory atherosclerosis. The goal of this study was to determine if P. gingivalis infection accelerates inflammation and atherosclerosis in the innominate artery of mice, an artery which has been reported to exhibit many features of human atherosclerotic disease, including plaque rupture. METHODS AND
RESULTS: Apolipoprotein E-deficient (ApoE-/-) mice were orally infected with P. gingivalis, and magnetic resonance imaging (MRI) was used to monitor the progression of atherosclerosis in live mice. P. gingivalis infected mice exhibited a statistically significant increase in atherosclerotic plaque in the innominate artery as compared to uninfected mice. Polarized light microscopy and immunohistochemistry revealed that the innominate arteries of infected mice had increased lipids, macrophages and T cells as compared to uninfected mice. Increases in plaque, total cholesterol esters and cholesterol monohydrate crystals, macrophages, and T cells were prevented by immunization with heat-killed P. gingivalis prior to pathogen exposure.
CONCLUSIONS: These are the first studies to demonstrate progression of inflammatory plaque accumulation in the innominate arteries by in vivo MRI analysis following pathogen exposure, and to document protection from plaque progression in the innominate artery via immunization.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21251656      PMCID: PMC3057233          DOI: 10.1016/j.atherosclerosis.2010.12.009

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  40 in total

1.  Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases.

Authors:  H I Morrison; L F Ellison; G W Taylor
Journal:  J Cardiovasc Risk       Date:  1999-02

2.  Collagen-synthesizing cells in initial and advanced atherosclerotic lesions of human aorta.

Authors:  E R Andreeva; I M Pugach; A N Orekhov
Journal:  Atherosclerosis       Date:  1997-04       Impact factor: 5.162

3.  Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST).

Authors:  Moïse Desvarieux; Ryan T Demmer; Tatjana Rundek; Bernadette Boden-Albala; David R Jacobs; Ralph L Sacco; Panos N Papapanou
Journal:  Circulation       Date:  2005-02-08       Impact factor: 29.690

Review 4.  Mechanisms of plaque vulnerability and rupture.

Authors:  Prediman K Shah
Journal:  J Am Coll Cardiol       Date:  2003-02-19       Impact factor: 24.094

Review 5.  Preterm low birth weight and periodontal disease among African Americans.

Authors:  Ananda P Dasanayake; Shirley Russell; Doryck Boyd; Phoebus N Madianos; Teri Forster; Ed Hill
Journal:  Dent Clin North Am       Date:  2003-01

6.  Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice.

Authors:  Evanthia Lalla; Ira B Lamster; Marion A Hofmann; Loredana Bucciarelli; Adrienne P Jerud; Sid Tucker; Yan Lu; Panos N Papapanou; Ann Marie Schmidt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-06-19       Impact factor: 8.311

7.  Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Frank C Gibson; Charlie Hong; Hsin-Hua Chou; Hiromichi Yumoto; Jiqiu Chen; Egil Lien; Jodie Wong; Caroline Attardo Genco
Journal:  Circulation       Date:  2004-05-03       Impact factor: 29.690

8.  Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe.

Authors:  Catherine A Reardon; Lydia Blachowicz; John Lukens; Michael Nissenbaum; Godfrey S Getz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-06-05       Impact factor: 8.311

9.  Porphyromonas gingivalis-specific immunoglobulin G prevents P. gingivalis-elicited oral bone loss in a murine model.

Authors:  Frank C Gibson; Dario A Gonzalez; Jodie Wong; Caroline Attardo Genco
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  Identification and detection of in situ cellular and regional differences of lipid composition and class in lipid-rich tissue using hot stage polarizing light microscopy.

Authors:  D A Waugh; D M Small
Journal:  Lab Invest       Date:  1984-12       Impact factor: 5.662

View more
  39 in total

1.  Distinct roles for dietary lipids and Porphyromonas gingivalis infection on atherosclerosis progression and the gut microbiota.

Authors:  Carolyn D Kramer; Alexandra M Simas; Xianbao He; Robin R Ingalls; Ellen O Weinberg; Caroline Attardo Genco
Journal:  Anaerobe       Date:  2017-04-23       Impact factor: 3.331

2.  Murine Norovirus Infection Variably Alters Atherosclerosis in Mice Lacking Apolipoprotein E.

Authors:  Charlie C Hsu; Jisun Paik; Thea L Brabb; Kevin D O'Brien; Jinkyu Kim; Brittany G Sullivan; Kelly L Hudkins; Audrey Seamons; Jennifer C Finley; Stacey M Meeker; Lillian Maggio-Price
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

3.  A mouse model for pathogen-induced chronic inflammation at local and systemic sites.

Authors:  George Papadopoulos; Carolyn D Kramer; Connie S Slocum; Ellen O Weinberg; Ning Hua; Cynthia V Gudino; James A Hamilton; Caroline A Genco
Journal:  J Vis Exp       Date:  2014-08-08       Impact factor: 1.355

Review 4.  Role of macrophage TRPV4 in inflammation.

Authors:  Bidisha Dutta; Rakesh K Arya; Rishov Goswami; Mazen O Alharbi; Shweta Sharma; Shaik O Rahaman
Journal:  Lab Invest       Date:  2019-10-23       Impact factor: 5.662

Review 5.  Role of gut microbiota in atherosclerosis.

Authors:  Annika Lindskog Jonsson; Fredrik Bäckhed
Journal:  Nat Rev Cardiol       Date:  2016-12-01       Impact factor: 32.419

6.  Glycyrrhetinic acid inhibits Porphyromonas gingivalis lipopolysaccharide-induced vascular permeability via the suppression of interleukin-8.

Authors:  Su-Ryun Kim; Hwa-Jin Jeon; Hyun-Joo Park; Mi-Kyoung Kim; Woo-Soo Choi; Hye-Ock Jang; Soo-Kyung Bae; Chul-Ho Jeong; Moon-Kyoung Bae
Journal:  Inflamm Res       Date:  2012-10-13       Impact factor: 4.575

Review 7.  Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.

Authors:  James A Hamilton; Hatice Hasturk; Alpdogan Kantarci; Charles N Serhan; Thomas Van Dyke
Journal:  Curr Atheroscler Rep       Date:  2017-11-06       Impact factor: 5.113

Review 8.  Infectious burden and atherosclerosis: A clinical issue.

Authors:  Rosa Sessa; Marisa Di Pietro; Simone Filardo; Ombretta Turriziani
Journal:  World J Clin Cases       Date:  2014-07-16       Impact factor: 1.337

Review 9.  The role of the vascular dendritic cell network in atherosclerosis.

Authors:  Noah Alberts-Grill; Timothy L Denning; Amir Rezvan; Hanjoong Jo
Journal:  Am J Physiol Cell Physiol       Date:  2013-04-03       Impact factor: 4.249

10.  Xylitol, an anticaries agent, exhibits potent inhibition of inflammatory responses in human THP-1-derived macrophages infected with Porphyromonas gingivalis.

Authors:  Eunjoo Park; Hee Sam Na; Sheon Min Kim; Shannon Wallet; Seunghee Cha; Jin Chung
Journal:  J Periodontol       Date:  2014-03-04       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.